The Clorox Company
CLX · NYSE
Earnings history and estimates
Reported and estimated revenue, EPS and post-earnings movement.
| Period | Date | Revenue actual | Revenue estimate | EPS actual | EPS estimate | 1D move |
|---|---|---|---|---|---|---|
| 2026 Q4 | August 3, 2026 | — | 1.91B | — | 1.64 | — |
| 2026 Q3 | April 30, 2026 | 1.67B | 1.67B | 1.54 | 1.48 | -9.67% |
| 2026 Q2 | February 3, 2026 | 1.67B | 1.64B | 1.39 | 1.43 | +2.43% |
| 2026 Q1 | November 3, 2025 | 1.43B | 1.40B | 0.85 | 0.78 | +1.17% |
| 2025 Q4 | July 31, 2025 | 1.99B | 1.93B | 2.87 | 2.24 | -1.96% |
| 2025 Q3 | May 5, 2025 | 1.67B | 1.72B | 1.45 | 1.57 | -2.41% |
| 2025 Q2 | February 3, 2025 | 1.69B | 1.76B | 1.55 | 1.39 | -7.24% |
| 2025 Q1 | October 30, 2024 | 1.76B | 1.65B | 1.86 | 1.36 | +1.30% |
| 2024 Q4 | August 1, 2024 | 1.90B | 1.95B | 1.82 | 1.54 | +7.42% |
| 2024 Q3 | April 30, 2024 | 1.81B | 1.87B | 1.71 | 1.33 | -5.57% |
| 2024 Q2 | February 1, 2024 | 1.99B | 1.80B | 2.16 | 1.08 | +5.62% |
| 2024 Q1 | November 1, 2023 | 1.39B | 1.31B | 0.49 | -0.20 | +6.61% |
| 2023 Q4 | August 2, 2023 | 2.02B | 1.88B | 1.67 | 1.19 | +8.96% |
| 2023 Q3 | May 2, 2023 | 1.92B | 1.82B | 1.51 | 1.20 | +4.70% |
| 2023 Q2 | February 2, 2023 | 1.72B | 1.66B | 0.98 | 0.66 | +9.77% |
| 2023 Q1 | November 1, 2022 | 1.74B | 1.69B | 0.93 | 0.73 | -6.13% |